Search research articles
Contact Us
Filters
Showing results (631-640 of 658) with videos related to
Page
of 66
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern
Bárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies
Mark M Painter, Timothy S Johnston, Kendall A Lundgreen, et al.
Iscience
|
August 18, 2025
Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine
Yohana Martínez-Balboa, Linmar Rodríguez-Guilarte, Constanza Méndez, et al.
Immunity
|
August 12, 2022
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
Yu Gao, Curtis Cai, David Wullimann, et al.
Nature Immunology
|
September 22, 2023
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Mark M Painter, Timothy S Johnston, Kendall A Lundgreen, et al.
Journal of Hematology & Oncology
|
April 3, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, et al.
Mbio
|
August 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
Bárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Elife
|
October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
Nicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
BMC Medicine
|
December 15, 2025
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity
Constanza Méndez, Linmar Rodríguez-Guilarte, Pablo A Palacios, et al.
Ebiomedicine
|
April 26, 2023
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Constanza Méndez, Hernán F Peñaloza, Bárbara M Schultz, et al.
Page
of 66
Search research articles
Search
Showing results (631-640 of 658) with videos related to
Sort By:
Page
of 66
Medrxiv : the Preprint Server for Health Sciences
|
April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern
Bárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies
Mark M Painter, Timothy S Johnston, Kendall A Lundgreen, et al.
Iscience
|
August 18, 2025
Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine
Yohana Martínez-Balboa, Linmar Rodríguez-Guilarte, Constanza Méndez, et al.
Immunity
|
August 12, 2022
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
Yu Gao, Curtis Cai, David Wullimann, et al.
Nature Immunology
|
September 22, 2023
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Mark M Painter, Timothy S Johnston, Kendall A Lundgreen, et al.
Journal of Hematology & Oncology
|
April 3, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, et al.
Mbio
|
August 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
Bárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Elife
|
October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
Nicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
BMC Medicine
|
December 15, 2025
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity
Constanza Méndez, Linmar Rodríguez-Guilarte, Pablo A Palacios, et al.
Ebiomedicine
|
April 26, 2023
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Constanza Méndez, Hernán F Peñaloza, Bárbara M Schultz, et al.
Page
of 66